Travere Therapeutics (TVTX) Gross Margin (2014 - 2026)
Travere Therapeutics' Gross Margin was 98.72% in Q3 2026, down 0.32 percentage points from 99.04% a year earlier but up 0.01 percentage points from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Gross Margin (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Travere Therapeutics' Gross Margin was 98.53% through Sep 30, 2026, up 0.91 percentage points year-over-year; for FY2025, it came in at 97.89%, up 1.21 percentage points from FY2024.
- Gross Margin shows a five-year change of +0.98 percentage points (FY2020 to FY2025).
- In earlier years, Gross Margin was 96.68% in FY2024 (+4.56 pp), 92.12% in FY2023 (-3.85 pp) and 95.96% in FY2022.
- Quarterly Gross Margin has moved between 86.58% (Q1 2023) and 108.92% (Q4 2021) over five years.
- Compared with a year earlier, Gross Margin was higher in six of the last eight quarters, with an average year-over-year change of +1.76 percentage points.
- The best year-over-year quarter for Gross Margin over five years was Q4 2021 (a gain of 12.98 percentage points); the worst was Q4 2022 (a drop of 11.88 percentage points).
- Per Business Quant data, TVTX's Gross Margin in the three quarters before Q3 2026 was 98.72% (Q2 2026), 98.47% (Q1 2026) and 98.03% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 75.71% |
| 10 | Travere Therapeutics | 4.97 Bn | 4.56 Bn | 221.70 Mn | 98.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 98.72% |
| Jun 30, 2026 | 98.72% |
| Mar 31, 2026 | 98.47% |
| Dec 31, 2025 | 98.03% |
| Sep 30, 2025 | 99.04% |
| Jun 30, 2025 | 98.67% |
| Mar 31, 2025 | 94.28% |
| Dec 31, 2024 | 96.59% |
| Sep 30, 2024 | 97.41% |
| Jun 30, 2024 | 96.19% |
| Mar 31, 2024 | 96.36% |
| Dec 31, 2023 | 89.87% |
| Sep 30, 2023 | 96.53% |
| Jun 30, 2023 | 95.49% |
| Mar 31, 2023 | 86.58% |
| Dec 31, 2022 | 97.04% |
| Sep 30, 2022 | 96.03% |
| Jun 30, 2022 | 92.84% |
| Mar 31, 2022 | 90.87% |
| Dec 31, 2021 | 108.92% |
API Access
Travere Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();